No black box warning on record for Vyndaqel
As of the latest FDA labeling reviewed, Vyndaqel (TAFAMIDIS MEGLUMINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vyndaqel medicine page for the complete safety profile.